Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of macrolide

A macrolide and ring-closing reaction technology, applied in the field of macrolide preparation, can solve the problems of low conversion rate, difficult purification, affecting the quality of finished products, etc., and achieves convenient post-processing, less side reactions, and safe operation. Effect

Active Publication Date: 2020-11-06
ZHEJIANG JINGXIN PHARMA +1
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the poorer solubility of compound intermediate II after desugaring and oxidation than intermediate CL-1, the reaction is difficult and the conversion rate is low; moreover, when the exposed amino group is deprotected, impurities of the following formula 1 and formula 2 will be produced, These two impurities are produced when the side chain of aminotriazole and methyl benzoate (or methyl acetate) undergo acylation side-reactions. Not only does the cost increase due to the consumption of more amino side chains, but also the by-product is difficult to purify. Affects the finished product quality of the final product Solithromycin IA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of macrolide
  • A kind of preparation method of macrolide
  • A kind of preparation method of macrolide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0059] Example 1 Preparation of compound of formula III-1 (R=-AcO)

[0060]

[0061] Dissolve 2.05g of the acetyl-protected compound of formula II-1 (2.90mmol) in 20ml of DMF / THF mixed solution (9:1), add 0.39g potassium tert-butoxide (3.48mmol) in batches at -20°C After completion, the mixture was stirred at -20°C for 0.5 hours, and then 1.01 g of NFSI (N-fluorobisbenzenesulfonamide) (3.19 mmol) was added. After the addition, the reaction was continued at -20°C for two hours. After sampling HPLC to detect the completion of the reaction, add a small amount of water to quench the reaction, dilute the reaction solution with 50ml ethyl acetate, then wash with saturated brine several times (50ml / time), dry with anhydrous sodium sulfate, filter and spin dry to obtain the crude product (can be Used directly in the next step). The crude product was purified by column chromatography (silica gel 200-300 mesh, Qingdao Huanghai), and 4 L ethyl acetate was used as the eluent to obtain 1.57 ...

Embodiment 2

[0063] Example 2 Preparation of compound of formula IV-1

[0064]

[0065] 7.23g of compound III-1 (0.01mol) was dissolved in 100ml of methanol and stirred at room temperature overnight. After sampling to detect the completion of the reaction, the solvent of the reaction solution was evaporated to obtain 7 g of white solid, and the crude product can be used directly in the next step. The crude product was purified by column chromatography (silica gel 200-300 mesh, Qingdao Huanghai), 4L dichloromethane: methanol = 30:1 and 1% triethylamine as the eluent, to obtain 5.78g foamy white solid IV-1 (collected Rate 85%).

[0066] ESI(M+1)=682.

Embodiment 3

[0067] Example 3 Preparation of Solithromycin of Formula IA (Cp=-NH 2 )

[0068]

[0069] 6.82 g of the compound of formula IV-1 (0.01 mol) and 6.93 g of the compound of formula VA-1 (0.03 mol) were mixed in 100 ml of acetonitrile: water = 9:1, and the above mixture was heated to reflux overnight. Sampling to detect the completion of the reaction, stop heating, after the reaction solution is cooled to room temperature, evaporate the organic solvent, dilute with 50ml of water, extract with 20ml of dichloromethane*3, combine the organic phases, dry with anhydrous sodium sulfate, filter with suction, spin dry , Column chromatography purification, (silica gel 200-300 mesh, Qingdao Huanghai), 4L dichloromethane: methanol = 30:1 and 1% triethylamine as the eluent, to obtain 6.34g foamy white solid, namely Soliomyces IA (yield 75%).

[0070] ESI(M+1) / 2=423.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparing method of macrolide. The method comprises the steps that firstly, a hydroxide radical protecting group is desugared, then the desugared hydroxide radical protectinggroup and a side chain compound are in direct splice joint and ring closing to obtain macrolide. By means of the reaction, the defects in the prior art that side reactions easily occur in the last step of desugaring the hydroxide radical protecting group, and impurities difficult to desorb and purify are generated are overcome. Therefore, the purity of the product of macrolide, particularly solithromycinm obtained according to the method is higher, few side reactions are caused, aftertreatment is convenient, and the preparing method is safe to operate and suitable for large-scale production.

Description

Technical field [0001] The invention belongs to the field of medicine synthesis and relates to a preparation method of macrolides. Background technique [0002] It is well known that macrolides can be used to treat various infectious diseases, can effectively treat and prevent infections caused by a broad spectrum of bacteria and protozoal pathogens, and they are also suitable for the treatment of respiratory tract infections and soft tissue infections. The macrolide compound is characterized by the presence of a large lactone ring, which is generally a 14-membered, 15-membered or 16-membered macrolide. One or more sugars can be attached to it, including deoxy sugars such as cladine Sugar and deglycosamine. Erythromycin is the first such compound to be introduced into clinical practice. Its molecular structure includes a 14-membered macrolide with two sugar moieties and a ketolactone ring moiety in its molecule. Therefore, ketolactone represents a relatively new category of mac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H17/08C07H17/00C07H1/00
CPCC07H1/00C07H17/00C07H17/08Y02P20/55
Inventor 徐辉雷平生赵哲辉徐苗焕陈鉴东侯建
Owner ZHEJIANG JINGXIN PHARMA